Jin T. E. Lim

(−)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells

Masahito Shimizu, Atsuko Deguchi, Jin T. E. Lim et al. · Clinical Cancer Research · 2005 · 344 citations · Full text

Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction

Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim et al. · Journal of Experimental Therapeutics and Oncology · 2002 · 232 citations

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines

Jin T. E. Lim, Gary A. Piazza, Edward K. Han et al. · Biochemical Pharmacology · 1999 · 210 citations

Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.

Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim et al. · PubMed · 2003 · 156 citations

Breast Oncology, Chemoprevention Strategy, Downstream Signaling Pathways +19

Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.

Masumi Suzui, Muneyuki Masuda, Jin T. E. Lim et al. · PubMed · 2002 · 123 citations

Chemoprevention Strategy, Acyclic Retinoid, Cyclin D1 +18